Abiopharma

🔍 Bonenberger David J (Executive)

Company: PPL Corp (PPL)

Report Date: 2026-04-24

Detailed Transactions and Holdings:

• Acquired 217 shares of Common Stock at $38.75 per share (Direct)
  Date: 2026-04-24 | Code: M | equity_swap_involved: false | shares_owned_after: 72,056.25 | transaction_form_type: 4 | Footnotes: F1
• Sold 95 shares of Common Stock at $38.75 per share (Direct)
  Date: 2026-04-24 | Code: F | equity_swap_involved: false | shares_owned_after: 71,961.25 | transaction_form_type: 4 | Footnotes: F2, F1
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-04-24 | Code: H | nature_of_ownership: Held in trust pursuant to the Employee Stock Ownership Plan. | shares_owned_after: 5,111.13 | Footnotes: F1
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-04-24 | Code: H | nature_of_ownership: By Spouse in IRA. | shares_owned_after: 100.00
• Sold 217 shares of Stock Unit (SIP) (Derivative)
  Date: 2026-04-24 | Code: M | equity_swap_involved: false | transaction_form_type: 4 | Footnotes: F1, F3, F3, F1

Footnotes:

• F1: Total includes the reinvestment of dividends.
• F2: Shares withheld by the company at the request of the executive officer to pay taxes due following expiration of the applicable restriction period, under the terms of the Stock Incentive Plan (SIP).
• F3: The units vested on 04/24/2026 as the first installment of the restricted stock units granted on 04/25/2025. The remainder of the total grant of 649.535 restricted stock units will vest in two subsequent installments on 04/25/2027 (216.511 shares) and 04/25/2028 (216.513 shares).